These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 773587)

  • 21. Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients.
    Robinson DS; Cooper TB; Howard D; Corcella J; Albright D
    J Clin Psychopharmacol; 1985 Apr; 5(2):83-8. PubMed ID: 3988974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
    Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
    Monteleone P; Fabrazzo M
    Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression, antidepressants, and plasma DBH.
    Mathew RJ; Ho BT; Davis C; Taylor D; Reck J
    Psychiatry Res; 1981 Dec; 5(3):331-4. PubMed ID: 6948312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of amitriptyline and therapeutic effect in non-delusional moderately to severely depressed in-patients: a therapeutic window relationship.
    Ulrich S; Northoff G; Wurthmann C; Partscht G; Pester U; Herscu H; Meyer FP
    Pharmacopsychiatry; 2001 Jan; 34(1):33-40. PubMed ID: 11229620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind study of dothiepin hydrochloride (Prothiaden) and amitriptyline in out-patients with masked depression.
    Dahl LE; Dencker SJ; Lundin L
    J Int Med Res; 1981; 9(2):103-7. PubMed ID: 7014282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic findings in patients undergoing amitriptyline treatment.
    Ziegler VE; Biggs JT
    Dis Nerv Syst; 1977 Sep; 38(9):697-9. PubMed ID: 902559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
    Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
    Miljković B; Pokrajac M; Timotijević I; Varagić V
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.
    Coppen A; Ghose K; Montgomery S; Rama Rao VA; Bailey J; Christiansen J; Mikkleson PL; van Praag HM; van de Poel F; Minsker EJ; Kozulja VG; Matussek N; Kungkunz G; Jłrgensen A
    Lancet; 1978 Jan; 1(8055):63-6. PubMed ID: 74566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: serum levels and clinical response.
    Mendlewicz J; Linkowski P; Rees JA
    Br J Psychiatry; 1980 Feb; 136():154-60. PubMed ID: 6989426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of tricyclic antidepressant therapy.
    Dawling S
    Clin Biochem; 1982 Feb; 15(1):56-61. PubMed ID: 7067078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.
    Breyer-Pfaff U; Gaertner HJ; Kreuter F; Scharek G; Brinkschulte M; Wiatr R
    Psychopharmacology (Berl); 1982; 76(3):240-4. PubMed ID: 6808544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noxiptilin (Agedal)--a new tricyclic antidepressant with a faster onset of action? A double-blind, multicentre comparison with amitriptyline.
    Lingjaerde O; Asker T; Bugge A; Engstrand E; Eide A; Grinaker H; Herlofsen H; Ose E; Ofsti E
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):26-35. PubMed ID: 788000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo.
    Thomson J; Rankin H; Ashcroft GW; Yates CM; McQueen JK; Cummings SW
    Psychol Med; 1982 Nov; 12(4):741-51. PubMed ID: 7156248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind study of the therapeutic efficacy and tolerability of amitriptylinoxide in comparison with amitriptyline.
    Tegeler J; Klieser E; Lehmann E; Heinrich K
    Pharmacopsychiatry; 1990 Jan; 23(1):45-9. PubMed ID: 2179974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.